Clinical Update: Inflammatory Bowel Disease

Abstract

Disclaimer The document is a general guide to appropriate practice, to be followed subject to the clinician's judgment and the patient's preference in each individual case in the management of Inflammatory Bowel Disease. The clinical update is designed to provide information to assist in decision-making but is not exhaustive, nor does it cover every discrete situation. It is based on the best evidence available at the time of writing. The document is intended primarily for the use of clinicians in Australia, while complementing recent consensus statements published by the European Crohn's and Colitis Organisation (ECCO), British Society of Gastroenterology, American Gastroenterological Association and other international organisations. Every effort has been made to check drug dosage recommendations in this clinical update but it is still possible that errors have been missed. Furthermore, dosage recommendations are continually being revised and new adverse events recognised. Trade names used in this publication are for identification purposes only. Their use does not imply endorsement of any particular brand of drug.